AstraZeneca’s supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) has been accepted for Priority Review by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with…
Eli Lilly and Company (NYSE: LLY) announced a significant $4.5 billion investment to establish the Lilly Medicine Foundry, a state-of-the-art facility for advanced manufacturing and drug development. This innovative center…
AIVITA Biomedical, Inc., a biotech firm focused on pioneering stem cell applications, has announced a licensing agreement with LevEllis, a global skincare retailer. This partnership grants LevEllis the exclusive worldwide…
PharmaJet®, a leader in enhancing the efficacy of injectable treatments through innovative technology, has announced the appointment of Wouter Latour, M.D., as its new Chief Executive Officer (CEO). In addition…
Forge Biologics, a key player in Ajinomoto Bio-Pharma Services and a leading manufacturer of genetic medicines, has announced the launch of its FUEL™ manufacturing platform. This innovative platform aims to…
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA), an AI-driven biotherapeutics and technology company, and Biotheus Inc., a clinical-stage biotech specializing in biologics for oncology and inflammatory diseases, have announced the signing…
Arcus Biosciences, Inc. (NYSE: RCUS), a global biopharmaceutical company in the clinical stage, focused on developing innovative molecules and combination therapies for cancer patients, has announced a new collaboration with…
ImmunoTek Bio Centers, the largest independent operator and developer of blood plasma donation centers in the United States, is thrilled to announce its participation in International Plasma Awareness Week (IPAW)…
The global antibody drug market was valued at $218.6 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 11.2%, reaching $412.1 billion by…
PBIRx, Inc., a leader in pharmacy benefit consulting and auditing, is proud to announce the promotion of Stacy Mathews, MBA, to Director of Account Management. Since joining PBIRx as a…
Fresenius Kabi, a subsidiary of Fresenius specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic conditions, along with Formycon AG, a leading developer of…
Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, recently announced promising data from a study evaluating camonsertib, an oral small molecule ATR inhibitor, in combination with palliative radiation…